The progress and challenges of Alzheimer’s research and care
Posted on 17 July 2015 in Clinical Trials / Healthcare / Research
Ahead of the Alzheimer’s Association International Conference panellists from the Alzheimer’s Association, Biogen and the Alliance for Aging Research discuss some of the key failures of Alzheimer’s research, what we have learnt from this and the outlook for the future of clinical development and patient care.
They highlight a number of challenges facing Alzheimer’s research and clinical trials currently including the need for easier, non-invasive diagnosis tools and the need for more reliable tests or biomarkers that are less invasive. Patient recruitment and patient advocacy are also large hurdles to overcome, with trials in the US alone needing around 70,000 volunteers.
Find out more about the Cantab products for Alzheimer’s research, drug development and healthcare, which are being presented at the Alzheimer’s Association International Conference in Washington, DC this week.